Delta Fertility Kyrgyzstan was established in 2018 and has been operating for 7 years as of 2025. This article analyzes the center's characteristics from dimensions such as establishment time, service capacity, and laboratory standards, and discusses how to objectively evaluate overseas reproductive institutions.
Read MoreThe reliability of sperm morphology screening technology (IMSI, etc.) in Kyrgyzstan depends on laboratory equipment, embryologist experience, and technology type. This article evaluates from dimensions such as technical principles, equipment conditions, and personnel qualifications to help determine if it is suitable for your situation.
Read MoreThe safety of ovulation induction drugs in Kyrgyzstan depends on drug source, medical institution qualifications, and medication monitoring. This article analyzes drug standards, regulatory systems, and actual procedures to help patients rationally assess risks and avoid common misconceptions.
Read MoreThe National Reproductive Medical Center of Kyrgyzstan is the assisted reproductive institution with the largest number of doctors locally, with a team of about 12-15 reproductive specialists. Institutions such as the Bishkek International Reproductive Medical Center and the Happy Life Reproductive Center have between 5-10 doctors. This article provides decision-making reference from perspectives such as doctor configuration, specialty distribution, and patient matching.
Read MoreIn Kyrgyzstan, fresh and frozen embryo transfers each have specific indications for IVF. Fresh transfer has a shorter cycle without freezing, suitable for patients with good endometrial conditions and normal hormone levels; frozen transfer offers flexible timing and allows PGT screening, ideal for those needing genetic testing or suboptimal endometrial preparation. This article analyzes the differences and selection criteria from a medical decision-making perspective.
Read MoreObtaining the email contact of an assisted reproduction hospital in Kyrgyzstan is the first step in overseas IVF consultation. This article provides email finding methods, a pre-consultation checklist, email writing templates, and communication tips to help you establish first contact efficiently.
Read MoreThe total annual international patient volume at major assisted reproduction hospitals in Kyrgyzstan is estimated at 800-1,500 visits, concentrated in Bishkek. Data is based on hospital public information and industry observation estimates. Influenced by medical tourism policies, cost advantages, and technological development, the proportion of international patients is steadily rising.
Read MoreINCINTA Reproductive Center in Kyrgyzstan officially acquired the 'Tree of Life Reproductive Center' in Bishkek in 2023, rebranding it as INCINTA Bishkek Campus. The acquisition retains the original embryology lab team while introducing INCINTA's PGT technology and quality control system. This article analyzes the acquisition background, changes in hospital strength, process integration, and considerations from a patient decision-making perspective.
Read MorePGT-A genetic screening technology in Kyrgyzstan is primarily based on NGS next-generation sequencing, covering chromosomal aneuploidy screening. Bishkek reproductive centers can perform blastocyst biopsy + PGT-A, with a screening accuracy of approximately 95-98%, suitable for advanced maternal age, recurrent miscarriage, and recurrent implantation failure. The cost is about 2000-4000 USD/cycle, requiring advance planning for embryo culture and biopsy timing.
Read MoreProvides a reference for the ranking of international reproductive centers in Bishkek, Kyrgyzstan, analyzing the characteristics of each center from dimensions such as technology, law, cost, and target population, helping patients make rational choices based on their own circumstances. No official ranking, focusing on matching individual needs.
Read More别让疑问等太久 留下您的联系方式，我们会第一时间联系您
